A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Sherr, David H.
Funding for this research was provided by:
Foundation for the National Institutes of Health (R01GM103502-05)
unspecified valid from 2016-07-30